Synergism between Mimusops Elengi and Bauhinia Variegata Seed Extracts against Salmonella Enterica Serovar Typhi and Vibrio Cholerae O1 Biotype El Tor Serotype Ogawa Isolates
نویسندگان
چکیده
The current communication evaluates the antibacterial activity of Mimusops elengi (M. elengi) and Bauhinia variegata (B. variegata) seed extracts, alone and in combination, against Salmonella enterica serovar Typhi (S. typhi) and Vibrio cholerae O1 biotype El Tor serotype Ogawa (V. cholerae) isolates. The antibacterial activity of ethanolic extracts of bakul, M. elengi, seed (MSE; 500 μg) and kanchan, B. variegata, seed (BSE; 500 μg), alone and in combination, was determined following agar diffusion method, for a total of 16 S. typhi and V. cholerae isolates. The zone diameter of inhibition (ZDI) for the agents was recorded, and growth inhibitory indices (GIIs) were calculated. The V. cholerae and S. Typhi isolates had BSE (500 μg) and MSE (500 μg) ZDIs 12-17 mm and 13-15 mm, respectively. The GIIs of the BSE-MSE combination ranged 0.654 0.788 and 0.538 0.759 for the isolates of S. typhi and V. cholerae, respectively. The combined activity of BSE and MSE was synergistic against the test bacterial isolates, and the test plant extracts are potential in combating S. typhi and V. cholerae drug resistance and hence are important sources for the development of non-antibiotic drug(s) against S. typhi and V. cholerae infection.
منابع مشابه
Antibacterial activity of ciprofloxacin and trimethoprim, alone and in combinittion, against Vibrio cholerae O1 biotype El Tor serotype Ogawa isolates.
In this communication, the ciprofloxacin-trimethoprim (Cp-Tm) combination showed synergistic (Fractional Inhibitory Concentration, FIC index 0.399) and additive (FIC index 0.665-0.83) effects against Vibrio cholerae O1 biotype El Tor serotype Ogawa isolates having Cp MICs 10 microg/ml and Cp 0.66 microg/ml, respectively, following agar dilution checkerboard method. The time-kill study results d...
متن کاملEmergence of Vibrio cholerae O1 biotype El Tor serotype Inaba from the prevailing O1 Ogawa serotype strains in India.
The toxigenic Inaba serotype of Vibrio cholerae O1 biotype El Tor reappeared in India in 1998 and 1999, almost 10 years after its last dominance in Calcutta in 1989. Extensive molecular characterization by ribotyping, restriction fragment length polymorphism, and pulsed-field gel electrophoresis indicated that recent Inaba strains are remarkably different from the earlier Inaba strains but are ...
متن کاملPhenotypic and genetic characterization of vibrio cholerae O1 isolated from various regions of Kenya between 2007 and 2010
INTRODUCTION Cholera, a disease caused by Vibrio cholerae O1 and O139 remains an important public health problem globally. In the last decade, Kenya has experienced a steady increase of cholera cases. In 2009 alone, 11,769 cases were reported to the Ministry of Public Health and Sanitation. This study sought to describe the phenotypic characteristics of the isolated V. cholerae isolates. METH...
متن کاملEmergence of Tetracycline Resistant Vibrio cholerae O1 Biotype El Tor Serotype Ogawa with Classical ctxB Gene from a Cholera Outbreak in Odisha, Eastern India
In September 2010, a cholera outbreak was reported from Odisha, Eastern India. V. cholerae isolated from the clinical samples were biochemically and serologically confirmed as serogroup O1, biotype El Tor, and serotype Ogawa. Multiplex PCR screening revealed the presence of various genes, namely, ompW, ctxB, zot, rfbO1, tcp, ace, hlyA, ompU, rtx, and toxR, in all of the isolates. The isolates w...
متن کاملIdentification of Atypical El Tor V. cholerae O1 Ogawa Hosting SXT Element in Senegal, Africa
Vibrio cholerae O1 is the causative agent of cholera with classical and El Tor, two well-established biotypes. In last 20 years, hybrid strains of classical and El Tor and variant El Tor which carry classical ctxB have emerged worldwide. In 2004-2005, Senegal experienced major cholera epidemic with a number of cases totalling more than 31719 with approximately 458 fatal outcomes (CFR, 1.44%). I...
متن کامل